Update on afatinib-based combination regimens for the treatment of EGFR mutation-positive non-small-cell lung cancer.
Sign Up to like & getrecommendations! Published in 2017 at "Future oncology"
DOI: 10.2217/fon-2017-0240
Abstract: Department of Pneumology, Thoracic Oncology, University Hospital – Nantes, France *Author for correspondence: [email protected] read more here.
Keywords: update afatinib; regimens treatment; afatinib based; based combination ... See more keywords